Abstract 375: Phenotypic and molecular characterization of circulating tumor cells (CTCs) in patients with castration resistant prostate cancer (CRPC) undergoing treatment with abiraterone acetate or enzalutamide

Molecular characterization of circulating tumor cells (CTC) and CTC subpopulations in baseline and progressive metastatic castration resistant prostate cancer (mCRPC).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e16018 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e16018-e16018

Author(s):

Ryan Dittamore ◽

Jessica Louw ◽

Rachel Krupa ◽

Daniel Costin Danila ◽

Zaina Arslan ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Molecular Characterization ◽

Circulating Tumor Cells ◽

Serial genotypic characterization of circulating tumor cells (CTCs) in patients with metastatic castration resistant prostate cancer (mCRPC) undergoing treatment with abiraterone acetate (abi) or enzalutamide (enza)

Annals of Oncology ◽

10.1093/annonc/mdx390.042 ◽

2017 ◽

Vol 28 ◽

pp. v586

Author(s):

N. Dizman ◽

J. Patel ◽

M. He ◽

B. Foulk ◽

D.A. Smirnov ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Abiraterone Acetate ◽

Castration Resistant ◽

Genotypic Characterization

Synaptophysin expression on circulating tumor cells in patients with castration resistant prostate cancer undergoing treatment with abiraterone acetate or enzalutamide

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2017.12.006 ◽

2018 ◽

Vol 36 (4) ◽

pp. 162.e1-162.e6 ◽

Cited By ~ 8

Author(s):

Sumanta K. Pal ◽

Miaoling He ◽

Lin Chen ◽

Lixin Yang ◽

Raju Pillai ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Abiraterone Acetate ◽

A translational phase 2 study of cabozantinib in men with metastatic castration resistant prostate cancer with visceral metastases with characterization of circulating tumor cells and large oncosomes.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e16080 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e16080-e16080

Author(s):

Edwin M. Posadas ◽

Mourad Tighgohart ◽

YI-TSUNG LU ◽

Dolores Di Vizio ◽

David M. J. Hoffman ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Phase 2 ◽

Castration Resistant ◽

Phase 2 Study ◽

Visceral Metastases

Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer

Cancer Research ◽

10.1158/0008-5472.can-08-3667 ◽

2009 ◽

Vol 69 (7) ◽

pp. 2912-2918 ◽

Cited By ~ 418

Author(s):

Gerhardt Attard ◽

Joost F. Swennenhuis ◽

David Olmos ◽

Alison H.M. Reid ◽

Elaine Vickers ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Pten Gene ◽

Castration Resistant ◽

Gene Status

PD32-12 LONG-TERM FOLLOW-UP OF CIRCULATING TUMOR CELLS AS PREDICTORS FOR SURVIVAL IN MEN TREATED WITH ABIRATERONE ACETATE FOR CASTRATION RESISTANT PROSTATE CANCER FOLLOWING CHEMOTHERAPY

The Journal of Urology ◽

10.1016/j.juro.2016.02.688 ◽

2016 ◽

Vol 195 (4S) ◽

Author(s):

Christian Meyer ◽

Petra Strölin ◽

Hans Heinzer ◽

Klaus Pantel ◽

Sabine Riethdorf ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Abiraterone Acetate ◽

Castration Resistant ◽

Long Term Follow Up

Molecular and genomic characterization of invasive circulating tumor cells (iCTCs) from men with metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.11013 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 11013-11013 ◽

Cited By ~ 1

Author(s):

Terence W. Friedlander ◽

Gayatri Premasekharan ◽

Vy Ngo ◽

Evelyn Hang ◽

Julie Nicole Graff ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Castration Resistant ◽

Genomic Characterization

Abstract 1348: Characterization of SLFN11 protein expression in circulating tumor cells (CTCs) of patients with metastatic castration resistant prostate cancer (mCRPC) prior to platinum based chemotherapy

10.1158/1538-7445.am2019-1348 ◽

2019 ◽

Author(s):

Luisa Fernandez ◽

John Poirier ◽

Angel Rodriguez ◽

Melanie Hulling ◽

Robin Richardson ◽

...

Keyword(s):

Prostate Cancer ◽

Protein Expression ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Castration Resistant ◽

Platinum Based Chemotherapy

Abstract C9: Treatment response to abiraterone acetate (AA) in patients with castration-resistant prostate cancer (CRPC) based on circulating tumor cells (CTCs), prostate-specific antigen (PSA), and imaging

Cancer Research ◽

10.1158/1538-7445.prca2012-c9 ◽

2012 ◽

Vol 72 (4 Supplement) ◽

pp. C9-C9

Author(s):

Diletta Bianchini ◽

Alison Reid ◽

Gerhardt Attard ◽

Johann De Bono ◽

Shahneen Sandhu ◽

...

Keyword(s):

Prostate Cancer ◽

Treatment Response ◽

Prostate Specific Antigen ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Specific Antigen ◽

Abiraterone Acetate ◽

TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate

European Urology ◽

10.1016/j.eururo.2011.07.011 ◽

2011 ◽

Vol 60 (5) ◽

pp. 897-904 ◽

Cited By ~ 147

Author(s):

Daniel C. Danila ◽

Aseem Anand ◽

Clifford C. Sung ◽

Glenn Heller ◽

Margaret A. Leversha ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Predictive Biomarker ◽

Abiraterone Acetate ◽